Schlit, A F
Grandjean, P.
Donnez, Jacques
[UCL]
Lavenne, E.
Coagulation factors, 11-dehydro-TxB2 (metabolite of TxA2) and 6-keto-PGF1 alpha (metabolite of PGI2) levels in 87 women who were treated for 9 months with oral contraceptives (OC) containing low doses of oestrogens and progestogens (Triquilar, Trinovum or Cilest) were investigated. In plasma, increases in F I, II, VII, VIII-c and 11-dehydro-TxB2 levels, but no modification of 6-keto-PGF1 alpha were observed. In urine, FPA concentration rose, but no change occurred in 11-dehydro-TxB2 and 6-keto-PGF1 alpha levels. No marked difference between the 3 OC preparations were noted. These data, and particularly the large increase of 11-dehydro-TxB2 (p < 0.01) suggest that a hypercoagulable state persists in low dosage OC users.
Bibliographic reference |
Schlit, A F ; Grandjean, P. ; Donnez, Jacques ; Lavenne, E.. Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.. In: Contraception, Vol. 51, no. 1, p. 53-8 (1995) |
Permanent URL |
http://hdl.handle.net/2078.1/25271 |